Sabine D. Brookman-May, MD, FEBU🚴‍♀️🚴‍♀️🚴‍♀️🏔️⛷️⛰️

@brookmans76.bsky.social

Professor of Urology - Urologic Oncology, Sports Medicine @LMU Munich Senior VP Therapeutic Area Head Urologic Oncology, Aura Biosciences, Boston, MA (former J&J R&D) Avid Reader, Hiker, Skier, Enthusiastic Cyclist 🚴‍♀️🚴‍♀️🚴‍♀️ and Wine Grower in Mallorca 🍇🍷

#Nectin4 in GU vs other malignancies ✅ Nectin4 is more prevalent in GU cancers than others ✅ still more data needed on the prognostic and predictive value 👉 Interested in more data on how prior treatment impacts Nectin4 + how this could impact treatment sequence @oncodaily.bsky.social #BladderCancer

OncoDaily@oncodaily.bsky.social · 2y ago

Nectin-4 Positivity in GU Malignancies - Emanuele Crupi oncodaily.com/insight/eman... #BladderCancer #Cancer #GUMalignancies #Health #JCOPrecisionOncology #OncoDaily #Oncology #Medicine

Frailty in older adults w/ #ProstateCancer is a significant challenge, as it can affect both the prognosis and treatment decisions. Frailty results from aging-related declines in physiological reserves and exacerbated by both ADT & the cancer itself, leading to sarcopenia & reduced bone density

The Advanced Prostate Cancer Consensus Conference@apccc.bsky.social · 2y ago

Frailty in Older Adults with #ProstateCancer euoncology.europeanurology.com/article/S258... Tailored tx, including geriatric interventions & supportive care, are crucial for frail patients @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social @achoud72.bsky.social